Plavix and Light chain analysis increased - a phase IV clinical study of FDA data

Summary:

Light chain analysis increased is reported as a side effect among people who take Plavix (clopidogrel bisulfate), especially for people who are male, 60+ old, also take Revlimid, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Light chain analysis increased when taking Plavix. It is created by eHealthMe based on reports of 147,094 people who have side effects when taking Plavix from the FDA, and is updated regularly.

What is Plavix?

Plavix has active ingredients of clopidogrel bisulfate. It is often used in stent. eHealthMe is studying from 151,179 Plavix users. Check the latest studies of Plavix.

What is Light chain analysis increased?

Light chain analysis increased is found to be associated with 199 drugs and 149 conditions by eHealthMe. Check the latest studies of Light chain analysis increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

147,094 people reported to have side effects when taking Plavix.
Among them, 16 people (0.01%) have Light chain analysis increased.

Could Plavix cause Light chain analysis increased?

Among these 16 people:

What is the gender of people who have Light chain analysis increased when taking Plavix? *

female: 12.5 %
male: 87.5 %

What is the age of people who have Light chain analysis increased when taking Plavix? *

What are other drugs people take besides Plavix? *

What are other side effects people have besides Light chain analysis increased? *

Weakness: 3 people, 18.75%
Anaemia (lack of blood): 3 people, 18.75%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 3 people, 18.75%
Diarrhea: 3 people, 18.75%
General Physical Health Deterioration (weak health status): 2 people, 12.50%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 12.50%
Dyspnea Exertional: 2 people, 12.50%
Drowsiness: 2 people, 12.50%
Disease Progression: 2 people, 12.50%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 2 people, 12.50%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 62.50%
Leukaemia Plasmacytic (a progressive, malignant disease of the blood-forming organs): 1 person, 6.25%
Insomnia (sleeplessness): 1 person, 6.25%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 6.25%
High Blood Pressure: 1 person, 6.25%
Diarrhea: 1 person, 6.25%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 6.25%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 6.25%
Cardiac Failure Congestive: 1 person, 6.25%
Cardiac Failure: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Plavix and have Light chain analysis increased?

- Check whether Light chain analysis increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Plavix:

Plavix (151,179 reports)

Browse all side effects of Plavix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Light chain analysis increased:

Light chain analysis increased (199 drugs)

Browse all the conditions that are associated with Light chain analysis increased:

Light chain analysis increased (149 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clopidogrel bisulfate (the active ingredients of Plavix) and Plavix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.